Table 1 Patient demographics and tumour characteristics

From: Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer

 

N =49

(%)

Median preoperative age, years (range)

64.0 (48.0–77.0)

Median preoperative PSA, ng ml–1 (range)

11.0 (5.0–120.0)

Tumour stage

  

 pT2

24

(49.0)

 pT3

24

(49.0)

 pT4a

1

(2.0)

Pelvic nodes involved

  

 pN0

26

(53.1)

 pN1-2

10

(20.4)

 pNx

13

(26.5)

Surgical margins involved

20

(40.8)

Seminal vesicles involved

12

(24.5)

Gleason score

  

6

16

(32.7)

 =7

12

(24.5)

 >7

21

(42.9)